Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

46.24
Delayed Data
As of Sep 29
 -1.65 / -3.45%
Today’s Change
40.67
Today|||52-Week Range
68.00
-0.11%
Year-to-Date
No recent news for Dr.Reddy's Laboratories Ltd.

Today’s Trading

Previous close47.89
Today’s open47.11
Day’s range45.97 - 47.11
Volume264,204
Average volume (3 months)316,509
Market cap$8.2B
Dividend yield0.65%
Data as of 09/29/2016

Growth & Valuation

Earnings growth (last year)-15.85%
Earnings growth (this year)--
Earnings growth (next 5 years)+18.13%
Revenue growth (last year)-2.51%
P/E ratio0.5
Price/Sales3.28
Price/Book4.22

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc-3.48-4.80%
SGENSeattle Genetics Inc-2.04-3.69%
JAZZJazz Pharmaceuticals...-2.75-2.19%
ALKSAlkermes Plc-2.10-4.30%
Data as of 09/29/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.39
Annual revenue (last year)$2.4B
Annual profit (last year)$305.0M
Net profit margin12.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts

Search for Jobs